An in vivo avian model of human melanoma to perform rapid and robust preclinical studies

Metastatic melanoma patients carrying a BRAF(V600) mutation can be treated with a combination of BRAF and MEK inhibitors (BRAFi/MEKi), but innate and acquired resistance invariably occurs. Predicting patient response to targeted therapies is crucial to guide clinical decision. We describe here the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarrosson, Loraine, Dalle, Stéphane, Costechareyre, Clélia, Tang, Yaqi, Grimont, Maxime, Plaschka, Maud, Lacourrège, Marjorie, Teinturier, Romain, Le Bouar, Myrtille, Maucort‐Boulch, Delphine, Eberhardt, Anaïs, Castellani, Valérie, Caramel, Julie, Delloye‐Bourgeois, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994476/
https://www.ncbi.nlm.nih.gov/pubmed/36692026
http://dx.doi.org/10.15252/emmm.202216629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994476/
https://www.ncbi.nlm.nih.gov/pubmed/36692026
http://dx.doi.org/10.15252/emmm.202216629

Ejemplares similares